Downregulation of Spry-1, an inhibitor of GDNF/Ret, causes angiotensin II-induced ureteric bud branching

Kidney International

Volumn 74, Issue 10, 2008, Pages 1287-1293

  Yosypiv, Ihor V ^a   Boh, Mary K ^a   Spera, Melissa A ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Branching morphogenesis; c Ret; GDNF; Renin angiotensin; Spry1; Ureteric bud

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROTEIN RET; PROTEIN SPROUTY 1; SPROUTY PROTEIN; UNCLASSIFIED DRUG; WNT11 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL BUDDING; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; IN SITU HYBRIDIZATION; KIDNEY CELL; MESENCHYME CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; URETER;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; KIDNEY; MEMBRANE PROTEINS; MESODERM; MICE; MORPHOGENESIS; PHOSPHOPROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 1; URINARY TRACT; WNT PROTEINS;

EID: 55249099083     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.378     Document Type: Article

References (40)

1. Aufderheide E, Chiquet-Ehrismann R, Ekblom P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 1987; 105: 599-608.
2. Ekblom P. Developmentally regulated conversion of mesenchyme to epithelium. FASEB J 1989; 3: 2141-2150.
3. Hatini A, Huh SO, Herzlinger D et al. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 1996; 10: 1467-1478.
4. Sakurai H, Nigam S. In vitro branching tubulogenesis: implications for developmental and cystic disorders, nephron number, renal repair, and nephron engineering. Kidney Int 1998; 54: 14-26.
5. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1: 335-347.
6. Lisle SJ, Lewis RM, Petry CJ et al. Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br J Nutr 2003; 90: 33-39.
7. North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS Annual report 2006.
8. Brophy PD, Ostrom L, Lang KM et al. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 2001; 128: 4747-4756.
9. Pachnis V, Mankoo B, Costantini F. Expression of the c-ret protooncogene during mouse embryogenesis. Development 1993; 119: 1005-1017.
10. Majumdar A, Vainio S, Kispert A et al. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 2003; 130: 3175-3185.
11. Basson MA, Akbulut S, Watson-Johnson J et al. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 2005; 8: 229-239.
12. Basson MA, Watson-Johnson J, Shakya R et al. Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNF and Sprouty1. Dev Biol 2006; 299: 466-477.
13. Gribouval O, Gonzales M, Neuhaus T et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005; 37: 964-968.
14. Nagata M, Tanimoto K, Fukamizu A et al. Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 1996; 75: 745-753.
15. Takahashi N, Lopez ML, Cowhig Jr JE et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol 2005; 16: 125-132.
16. Esther Jr CR, Howard TE, Marino EM et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996; 7: 953-965.
17. 1B receptors for angiotensin II. Proc Natl Acad Sci USA 1998; 95: 15496-15501.
18. Tsuchida S, Matsusaka T, Chen X et al. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 1998; 101: 755-760.
19. Oshima K, Miyazaki Y, Brock JW et al. Angiotensin type II receptor expression and ureteral budding. J Urol 2001; 166: 1848-1852.
20. Yosypiv IV, Schroeder M, El-Dahr SS. Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis. J Am Soc Nephrol 2006; 17: 1005-1014.
21. Schuchardt A, D'Agati V, Larsson-Blomberg L et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994; 367: 380-383.
22. Moore MW, Klein RD, Farinas I et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996; 382: 76-79.
23. Costantini F, Shakya R. GDNF/Ret signaling and the development of the kidney. Bioessays 2006; 28: 117-127.
24. Iosipiv IV, Schroeder M. A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol 2003; 285: F199-F207.
25. Woolf AS, Price KL, Scambler PJ et al. Evolving concepts in human renal dysplasia. J Am Soc Nephrol 2004; 15: 998-1007.
26. Hellmich HL, Kos L, Cho ES et al. Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 1996; 54: 95-105.
27. Mason JM, Morrison DJ, Basson MA et al. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 2006; 16: 45-54.
28. Ushio-Fukai M, Hilenski L, Santanam N et al. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 2001; 276: 48269-48275.
29. Lim J, Wong ESM, Ong SH et al. Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation. Identification of a novel translocation domain. J Biol Chem 2000; 275: 32837-32845.
30. Pepicelli CV, Kispert A, Rowitch DH et al. GDNF induces branching and increased cell proliferation in the ureter of the mouse. Dev Biol 1997; 192: 193-198.
31. Michael L, Davies JA. Pattern and regulation of cell proliferation during murine ureteric bud development. J Anat 2004; 204: 241-255.
32. Meyer TN, Schwesinger C, Bush KT et al. Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney. Dev Biol 2004; 275: 44-67.
33. Carev D, Krnić D, Saraga M et al. Role of mitotic, proapoptotic and antiapoptotic factors in human kidney development. Pediatr Nephrol 2006; 21: 627-636.
34. Dziarmaga A, Eccles M, Goodyer P. Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice. J Am Soc Nephrol 2006; 17: 1568-1575.
35. Sheibani N, Scheef EA, Dimaio TA et al. Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J Cell Physiol 2007; 210: 616-625.
36. Fan H, Stefkova J, El-Dahr SS. Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway. Am J Physiol Renal Physiol 2006; 291: F670-F682.
37. Berry C, Touyz R, Dominiczak AF et al. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol 2001; 281: H2337-H2365.
38. Watanabe G, Lee RJ, Albanese C et al. Angiotensin II activation of cyclin D1-dependent kinase activity. J Biol Chem 1996; 271: 22570-22577.
39. Tang MJ, Cai Y, Tsai SJ et al. Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev Biol 2002; 243: 128-136.
40. Kim D, Dressler GR. PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev Biol 2007; 307: 290-299.